/Lists

Healthtech Late Stage Investors & VC Firms

494 firms in this list, with a median first check of $1M. 98 of them lead rounds. Generated from verified public data and updated continuously.

Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
82 people
Obvious Ventures
San FranciscoPre-Seed–Late Stage$250K – $6M
40 people
Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
55 people
Marlin Equity Partners
Hermosa BeachGrowth–Late Stage
75 people
Novo Holdings
CopenhagenSeed–Late Stage$1.1M – $54M
47 people
Bosch Ventures
StuttgartSeed–Late Stage$1.6M
47 people
Thompson Street Capital Partners
St. LouisGrowth–Late Stage$50M – $500M
62 people
Deutsche Beteiligungs AG
Frankfurt am MainGrowth–Late Stage
51 people
Altas Partners
TorontoGrowth–Late Stage
84 people
Dawson Partners
TorontoGrowth–Late Stage
85 people
Moscow Venture Fund (formerly Moscow Seed Fund)
MoscowPre-Seed–Late Stage
40 people
5AM Ventures
San FranciscoSeed–Late Stage$100K – $4M
41 people
Stifel Venture Banking
San FranciscoSeed–Late Stage
75 people
Kreos Capital
LondonSeries A–Late Stage
43 people
EQT Life Sciences
AmsterdamSeed–Late Stage$11M – $66M
59 people
Kaszek Ventures
MontevideoSeed–Late Stage
25 people
Oak Investment Partners
WiltonSeed–Late Stage
11 people
Tesi (Finnish Industry Investment Ltd)
HelsinkiSeed–Late Stage$5.4M – $16.2M
24 people
TriplePoint Capital
Menlo ParkSeed–Late Stage
67 people
SMBC Venture Capital
TokyoPre-Seed–Late Stage
27 people
BayPine
BostonGrowth–Late Stage
74 people
Advent International
BostonGrowth–Late Stage$1.1B
58 people
Lightbank
ChicagoSeed–Late Stage$500K – $5M
21 people
MPM BioImpact
BostonPre-Seed–Late Stage$1M – $15M
51 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.